Programme COMMITTEE
Heather Bryant
Dr Heather Bryant is Senior Scientific Lead at the Canadian Partnership Against Cancer. She initially joined the Partnership in January 2008 as its first Vice President, Cancer Control.
In that role, she developed and led a portfolio of pan-Canadian cancer control programs throughout the cancer continuum, including population-based prevention and cancer screening, diagnosis and care, patient centered reporting and palliative care, and research (including the launching of the Canadian Partnership for Tomorrow Project).
Heather has led in the development of cancer system performance reporting in Canada. Prior to joining the Partnership, she was Vice President, Population Health and Information at the Alberta Cancer Board for many years.
Dr Bryant was elected to the Union for International Cancer Control (UICC) Board of Directors in 2012 and served as a Board member until 2018. She is also the chair of the International Cancer Benchmarking Program, an international comparison of cancer survival and its antecedents carried out by Cancer Research UK. She has chaired many national cancer or research committees, including being the inaugural chair of the Institute of Cancer Research’s Advisory Board (Canadian Institutes for Health Research), the Canadian Breast Cancer Screening Initiative and the National Colorectal Cancer Screening Network.
Dr Bryant studied medicine at the University of Calgary, followed by a fellowship in community medicine and a PhD in epidemiology. She is a Clinical Professor in the departments of Community Health Sciences and Oncology at the University of Calgary. In 2015, she was named one of the 100 Most Powerful Women in Canada by the Women’s Executive Network.
Anil D'Cruz
30 years as an oncologist, current Director at Oncology Apollo Hospitals, Ex-director at Tata Memorial Hospital, Mumbai, India, researcher, administrator and crusader in the field of cancer control and currently serving as President-elect of UICC.
Anil has held leadership positions both nationally and internationally on Board of Directors/ governing council/ executive committee of numerous hospitals, governmental organisations, cancer care organisations, advocacy group & professional bodies.
Anil has served on the UICC Board of Directors (2 terms) including its membership, governance and finance committees. Some of his other UICC related appointments include Programme Committee co-chair for the 2016 World Cancer Congress in Paris and member of the World Cancer Congress Organising Committee for the Melbourne conference in 2014. Anil also served as Editor of Manual of Clinical Oncology (MCO), a UICC publication.
He is an active researcher with pivotal contributions and over 200 peer reviewed publications. Delivered over 300 lectures, 50 named orations, plenary lectures and keynote presentations around the globe. His main areas of interest apart from his clinical responsibilities are in tobacco advocacy, cost effective treatment and health economics.
2020 World Cancer Congress Themes & CO-CHAIRS
1. HIGH IMPACT PREVENTION & RISK FACTOR REDUCTION
Todd Harper
Chief Executive Officer,
Cancer Council Victoria (CCA), Australia
In this room, the programme will explore primary prevention, including health promotion, examples of best practice in new evidence-based prevention strategies, and vaccines. Exposure to environmental risk factors unhealthy environments will be included, as well as new areas of development in policy, programme management, communications, and education.
Successful health promotion and cancer prevention
- Advocacy and partnerships
- Economics of prevention
- Evaluatio
- Media and Communications
- Regulation
- Programs
Major Cancer risk factors
- Alcohol and cancer
- Diet, weight and physical activity
- Role of sugar and sugary drinks
- Latest on biology of unhealthy weight and cancer
- Sugar and obesity impact on cancer
- Effective strategies to reduce sugar consumption
- Physical activity and cancer
- Tobacco and cancer
- Tobacco product regulation
- Plain packaging of tobacco products
- UV and cancer
- Environment and workplace
Prevention and cancer inequalities
- People with mental illness
- Indigenous populations
- Culturally diverse populations
- Low income populations
- Health literacy
- Access to information and programs
2. Promising cancer research & Progress
Craig C.Earle
Vice-President, Canadian Partnership Against Cancer (CPAC), Canada
The programme of this room would highlight recent scientific and clinical advances in the diagnosis and treatment of cancer, and the latest research to overcome inequalities in cancer care. The sessions should also highlight the potential impact of scientific, clinical and technological advancements such as biotech breakthroughs and recent clinical trials. This Programme will also include sessions on how to translate findings into clinical practices.
- AI/deep learning/big data/modeling.
- Immunotherapy, including toxicity
- personalized medicine: Genomics/epigenetics/proteomics
- Microbiome
- Genetic predisposition syndromes
- New clinical trial methodologies
- Oncogeriatrics
- Biosimilars
- Tumor microenvironment
- PROs/QoL
- New indications for stem cell transplant
- Early integration of palliative care
- Imaging/radiomics/radiopharmaceuticals
- cannabis
- Oncocardiology
3. Optimising Screening & Early diagnosis
Partha Basu
Head, Screening Group, Early Detection&Prevention Section, Agency for Research on Cancer (IARC), France
Ophira Ginsburg
Director, High-Risk Cancer Program, Perlmutter cancer center, NYU Langone Health, United-States
The programme content in this room will address the need for improved systems and pathways that result in cancer being detected and treated at an early stage. It will include presentations on optimization of existing screening efforts and programs, addressing barriers to establishing evidence based as well as -informed screening programs, Effective initiatives to systematically detect cancer earlier through primary care, improved diagnostic strategies, and improved pathways to access diagnostic services will also be covered.
- Early diagnosis of common cancers –implementation, challenges and opportunities
- Improving health workforce in cancer screening and early diagnosis
- Community engagement in cancer early detection
- Screening coverage, programmes and need on cervical cancer, breast cancer, lung cancer, prostate cancer
- Introduction of cancer screening programme – decision factors
- Prostate cancer screening – Implement in high risk populations
- Risk based screening – new perspectives/new evidence:from genomics to risk prediction models
- Improving quality and reducing inequities in cancer early detection
- Artificial intelligence and other new technologies in cancer early detection
4. Ensuring sustainable healthcare systems
Susan Henshall
Chief Executive Officer, C/Can Foundation, Switzerland
Arnie Purushotham
Director, King's Health Partners Integrated Cancer Center (ICC), King's College London, United Kingdom
The programme of this room adds value by channelling intellectual effort, collaborations, access to shared resources to stimulate dialogue about implementing global commitments at a national level, as well as strengthen national, regional and local health systems and guiding quality improvement acrossdifferent aspects of sustainable development, policy and planning, infrastructure, measurement, reporting and performance.
- UHC and making cancer care affordable
- Using technology to drive access
- Building the cancer workforce
- Delivering quality cancer services
- Cancer and sustainable cities
- Political systems of cancer
- Health systems research
- Building cancer information systems
- New models of care
- Health Financing
- Partnerships for the Goals: advancing SDG17
- Legal and Regulatory systems
5. Improving patient outcomes – Cancer care & Palliative care
Stephen R.Connor
Executive Director, Worldwide Hospice Palliative Care Alliance (WHPCA), United Kingdom
Ann Lee
Clinical Professor and Head,Department of Clinical Oncology,The University of Hong Kong, China
The programme of this room should examine novel interventions to support patient engagement and survivorship in a variety of cancer care delivery settings. It focuses on patient experience and quality of outcome, exploring patient and family engagement, wrestles with rights and expectations of cancer patients and their families and the challenges of access, fairness and consistency of experience and care. It will explore the role of complimentary therapies, identify experiences with alternative treatments and invite challenging discussions about balance of investment and patient power. It invites exploration of measurement issues, prioritisation of service delivery, communication skills of health care professionals, tools to drive health care facility culture and survivorship. Fundamental questions around palliative care, pain relief and end of life issues are invited.
- Overcoming barriers to palliative care globally
- Universal Health Coverage & advocacy for palliative care
- Measuring outcomes in Palliative care (clinical, organizational, utilization, national progress)
- Access to essential palliative and cancer treatment medicines
- Improving and standardizing education and training in palliative care
- Health workforce issues in Palliative care
- Clinical guideline development for improved symptom management
- Policy development in Palliative care
- Palliative care in primary care
- Implementation of palliative care in resource limited settings
- Sustainable financing for palliative care
- Patient and caregiver perspectives on palliative needs
6. Successful Partnerships & Fundraising
Carlos Rodriguez-Galindo
Director and Executive President, International Outreach Program, St Jude Children's Hospital, United-States
Maya Helbaoui
Public Affairs Lead, Middlle East, Roche Lebanon
Through the programme of this room, Individuals and organisations will have the opportunity to strengthen their skills, competencies and abilities, allowing them to achieve measurable and sustainable results in their own environment. The objective is to increase the global cancer community’s effectiveness and performance to enable them to successfully respond to fast changing economic conditions, new stakeholders’ behaviours, political and regulatory challenges and technological trends.
Fundraising
- Importance of the strategic plan
- Roles and responsibilities for fundraising
- Fundraising methods - mapping donors, building relationships, accountability & credibility
- Governance and administration
- Message and focus (broad vs. narrow, medical care vs. psychosocial care, etc)
- Patient/parent supportive groups
Public-Private partnership
- Importance and value of Public-Private partnerships in healthcare in light of the increasing challenges the health systems are facing
- How can the Public-Private partnerships enable better access to patients/ efficiency in health systems /key stakeholders involved and their roles
- Successful examples and innovative Public-Private projects
- Pharmaceutical companies and facilitating access to new treatments
7. Tackling priorities in different regions of the world
Africa
Zainab Shinkafu Bagudu
CEO, Medicaid Cancer Foundation, Nigeria
Americas
Alejandro Mohar
Director, National Cancer Institute (InCan),Mexico
Eastern Mediterranean
Wahid Al Kharusi
President, Oman Cancer Association, Oman
Europe
Ulrika Årehed Kågström
Secretary General, Swedish Cancer Society, Sweden
Western Pacific
Jeff Dunn
CEO, Prostate Cancer
Foundation of Australia, Australia
South-East Asia
Daiming Fan
President, China Anti-Cancer Association, China
LMIC SESSION
Ana Cristina Mendes Pereira
CEO, Instituto Nacional de Cancer, Brazil
HIC SESSION
Nick Grant
Executive Director, International Partnerships at Cancer Research UK, United Kingdom
The programme of this room would highlight the specific cancer challenges faced in different regions of the World. These sessions would be open to all delegates who want to learn of experiences in their own region, or to earn from other regions.
- Coming soon